Apellis Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:1JK Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
16 Sep 24	Sell€6,249	James Chopas	Individual	192	€32.55
03 Sep 24	Sell€19,674	James Chopas	Individual	550	€35.77
19 Mar 24	Sell€983,563	Epidarex Capital	Company	18,681	€52.65
18 Mar 24	Sell€518,813	Mark Delong	Individual	9,913	€52.34
15 Mar 24	Sell€9,541	James Chopas	Individual	184	€51.85
13 Mar 24	Sell€590,102	Nur Nicholson	Individual	11,220	€53.12
12 Feb 24	Sell€37,556	Mark Delong	Individual	597	€62.91
12 Feb 24	Sell€90,021	Timothy Sullivan	Individual	1,431	€62.91
12 Feb 24	Sell€72,218	Adam Townsend	Individual	1,148	€62.91
12 Feb 24	Sell€49,131	David Watson	Individual	781	€62.91
12 Feb 24	Sell€249,242	Cedric Francois	Individual	3,962	€62.91
12 Feb 24	Sell€72,218	Pascal Deschatelets	Individual	1,148	€62.91
29 Jan 24	Sell€21,787	Mark Delong	Individual	367	€59.37
29 Jan 24	Sell€16,563	Jeffrey Eisele	Individual	279	€59.37
29 Jan 24	Sell€168,778	Cedric Francois	Individual	2,843	€59.37
29 Jan 24	Sell€51,886	Pascal Deschatelets	Individual	874	€59.37
29 Jan 24	Sell€53,786	Adam Townsend	Individual	906	€59.37
29 Jan 24	Sell€53,786	David Watson	Individual	906	€59.37
29 Jan 24	Sell€49,571	Nur Nicholson	Individual	835	€59.37
29 Jan 24	Sell€53,786	Timothy Sullivan	Individual	906	€59.37
29 Jan 24	Sell€21,787	Karen Lewis	Individual	367	€59.37
22 Jan 24	Sell€233,551	Pascal Deschatelets	Individual	3,913	€59.69
22 Jan 24	Sell€203,708	Adam Townsend	Individual	3,413	€59.69
22 Jan 24	Sell€249,725	David Watson	Individual	4,184	€59.69
22 Jan 24	Sell€103,734	Karen Lewis	Individual	1,738	€59.69
22 Jan 24	Sell€154,765	Nur Nicholson	Individual	2,593	€59.69
22 Jan 24	Sell€211,944	Timothy Sullivan	Individual	3,551	€59.69
22 Jan 24	Sell€82,605	Mark Delong	Individual	1,384	€59.69
22 Jan 24	Sell€63,327	James Chopas	Individual	1,061	€59.69
22 Jan 24	Sell€95,915	Jeffrey Eisele	Individual	1,607	€59.69
22 Jan 24	Sell€801,640	Cedric Francois	Individual	13,431	€59.69
16 Jan 24	Sell€481,504	Cedric Francois	Individual	7,851	€61.33
16 Jan 24	Sell€100,091	Karen Lewis	Individual	1,632	€61.33
16 Jan 24	Sell€137,073	Timothy Sullivan	Individual	2,235	€61.33
16 Jan 24	Sell€113,890	Nur Nicholson	Individual	1,857	€61.33
16 Jan 24	Sell€100,091	Pascal Deschatelets	Individual	1,632	€61.33
16 Jan 24	Sell€137,073	Adam Townsend	Individual	2,235	€61.33
16 Jan 24	Sell€260,040	David Watson	Individual	4,240	€61.33
16 Jan 24	Sell€26,863	Jeffrey Eisele	Individual	438	€61.33
16 Jan 24	Sell€100,030	Mark Delong	Individual	1,631	€61.33
16 Jan 24	Sell€52,989	James Chopas	Individual	864	€61.33
04 Jan 24	Sell€150,751	Caroline Baumal	Individual	2,751	€54.80
26 Dec 23	Sell€3,566	Jeffrey Eisele	Individual	68	€52.45
01 Dec 23	Sell€1,350,888	Epidarex Capital	Company	24,000	€56.29
21 Nov 23	Sell€223,284	Cedric Francois	Individual	5,000	€44.66
17 Nov 23	Sell€408,428	A. Dunlop	Individual	8,894	€45.92
23 Oct 23	Sell€5,669	Mark Delong	Individual	131	€43.27
23 Oct 23	Sell€5,712	James Chopas	Individual	132	€43.27
17 Oct 23	Sell€1,111,085	Epidarex Capital	Company	24,000	€46.30

Insider Trading Volume

Insider Buying: 1JK insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of 1JK?
Owner Type	Number of Shares	Ownership Percentage
State or Government	45,445	0.0338%
Individual Insiders	4,362,803	3.24%
VC/PE Firms	12,806,342	9.52%
Hedge Funds	22,718,536	16.9%
Institutions	94,594,132	70.3%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 3.4%.

Top Shareholders

Top 25 shareholders own 90.42% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
13.5%	Wellington Management Group LLP	16,388,697	€481.9m	8.84%	0.08%
10.5%	The Morningside Group Limited	12,806,342	€376.5m	0%	85.08%
9.53%	EcoR1 Capital, LLC	11,607,425	€341.3m	2.2%	11.06%
9.12%	Avoro Capital Advisors LLC	11,111,111	€326.7m	0%	4.51%
8.06%	The Vanguard Group, Inc.	9,809,552	€288.4m	3.19%	no data
4.76%	BlackRock, Inc.	5,795,272	€170.4m	5.47%	no data
4.37%	T. Rowe Price Group, Inc.	5,324,838	€156.6m	-24.6%	0.02%
3.41%	State Street Global Advisors, Inc.	4,146,694	€121.9m	42.5%	0.01%
2.95%	Jennison Associates LLC	3,591,416	€105.6m	10.8%	0.07%
2.71%	FMR LLC	3,299,742	€97.0m	51.5%	0.01%
2.57%	JP Morgan Asset Management	3,131,953	€92.1m	46.9%	0.01%
2.37%	Octagon Capital Advisors LP	2,880,880	€84.7m	2.63%	14.16%
2.05%	Deep Track Capital, LP	2,500,000	€73.5m	150%	2.11%
1.66%	Morgan Stanley, Investment Banking and Brokerage Investments	2,016,220	€59.3m	34.2%	0.01%
1.51%	Cedric Francois	1,834,224	€53.9m	0%	no data
1.49%	Deutsche Asset & Wealth Management	1,819,604	€53.5m	14.2%	0.02%
1.47%	Geode Capital Management, LLC	1,787,917	€52.6m	5.8%	no data
1.42%	Tavistock Life Sciences	1,726,000	€50.7m	0%	2.68%
1.2%	Artal Group S.A.	1,467,080	€43.1m	11.5%	1.12%
1.15%	Fiera Capital Corporation	1,401,190	€41.2m	47.7%	0.1%
1.07%	OrbiMed Advisors LLC	1,302,800	€38.3m	0.39%	0.57%
0.91%	Pascal Deschatelets	1,113,897	€32.8m	2.48%	no data
0.89%	Invesco Ltd.	1,084,514	€31.9m	44.8%	0.01%
0.89%	Norges Bank Investment Management	1,079,605	€31.7m	14.1%	no data
0.89%	Polar Capital Holdings Plc	1,079,440	€31.7m	2.37%	0.13%